MedPath

3TC

3TC

Approved
DIN Number

02192683

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

viiv healthcare ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02192683
AIG Number0128157001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AF05 LAMIVUDINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

LAMIVUDINEActive
Strength: 150 MG
Monograph: LAMIVUDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.